期刊文献+

阴道脱落细胞检查联合人类染色体末端酶基因、c-myc 检测在宫颈癌诊断中的价值 被引量:5

The clinical value of Thinprep cytology test combined with h -TERC and c -myc in the diagnosis of cervical ;cancer
原文传递
导出
摘要 目的:探讨阴道脱落细胞检查(TCT)结合人类染色体末端酶基因(h-TERC)和 c-myc 检测在宫颈癌中的价值。方法运用免疫荧光原位杂交技术检测近三年来该院宫颈癌患者500例的宫颈脱落细胞中h-TERC 和 c-myc 的表达,将其检测结果与 TCT 检测结果比较,将上述三种结果的任一阳性检测再进行病理学诊断标准来确定,且以病理诊断为准进行分析。结果在所检测的500例患者中,TCT 异常者132例(26.4%),h-TECR 异常者90例(18.0%),c-myc 异常者80例(16.0%),将270例患者进行阴道宫颈活检技术,在这些病例中,宫颈慢性炎者120例,宫颈病变者150例,其中宫颈上皮瘤变 CINⅠ52例(38.2%),CINⅡ50例(36.4%),CIN Ⅲ30例(18.2%),宫颈癌18例(7.3%)。在所检测的病例中,用原位杂交检测了h-TERC 的含量,其检测结果依次为18.1%、45.4%、52.5%、65.9%、100.0%,同样的 c-myc 的结果依次为21.4%、48.9%、56.7%、59.9%、100.0%,随着 TCT 检测结果的病理程度越高,h-TERC 和 c-myc 的表达越高。结论h-TERC 和 c-myc 检测联合 TCT 更能有效地检测宫颈癌患者的病理程度。 Objective To explore the clinical value of Thinprep cytology test (TCT)combined with h -TERC and c -myc in the diagnosis of cervical cancer.Methods hTERC amplification was detected by dual -color interphase fluorescence in situ hybridization (FISH),and the results were compared with TCT and histological examination.Examination the positive which TCT,h -TERC and c -myc by pathological examination.The final diag-nosis was determined by the pathological examination.Results TCT was abnormal in 26.4% of 500 case,18.0%abnormal h -TERC gene,16.0% abnormal c -myc gene.In 270 cases according to the cervical biopsy,the positive rate of chronic inflammation,cervical intraepithelial neoplasia (CIN)Ⅰ,CINⅡ,CINⅢ and cervical cancer:44.4%, 38.2%,36.4%,18.2%,and 7.3% respectively.The positive rates of h -TERC were 18.1%,45.4%,52.5%, 65.9% and 100.0%,respectively.The positive rates of c -myc were 21.4%,48.9%,56.7%,59.9% and 100.0%.With increased pathological grade,the expressions of h -TERC and c -myc were high.Conclusion TCT combined with h -TERC and c -myc can test cervical cancer more effective.
作者 毛海波
出处 《中国基层医药》 CAS 2015年第21期3211-3213,I0002,共4页 Chinese Journal of Primary Medicine and Pharmacy
关键词 细胞学检查 子宫肿瘤 Cytological examination Gene, h - TERC Gene, myc Uterine neoplasm
  • 相关文献

参考文献16

  • 1肖正华,林英,张晓静.妇科临床病例人乳头瘤病毒检测结果分析[J].中国微生态学杂志,2013,25(6):676-678. 被引量:9
  • 2Zhang D, Zhang Q, Zhou L, et al. Comparison of prevalence, viral load, physical status and expression of human papillomavirus-16,- 18 and-58 in esophageal and cervical cancer:a case-control study [ J ]. BMC Cancer ,2010,10 ( 1 ) :650.
  • 3Kim J J, Ortendahl J, Goldie SJ. Cost-effectiveness of HPV vacci- nation and cervical cancer screening in women over Age 30 in the United States[ J]. Ann Intern Meal,2009,151 (12) :538-545.
  • 4Sokolova I, Algeciras-Schimnich A, Song M, et al. Chromosomal biomarkers for detection of human papillomavirus associated ge- nomic instability in epithelial cells of cervical cytology specimens [J]. J Mol Diagn,2007,9(5) :604-611.
  • 5Heselmeyer-Haddad K, Sommerfeld K, White NM, et al. Genomic amplification of the human telomerase gcne (TERC) in pap smears predics the development of cervical cancer [ J ]. Am J Pathol,2005,166 (4) : 1229-1238.
  • 6Melnikow J, McGahan C, Sawaya GF, et al. Cervical intraepitheli- al neoplasia outcomes after treatment: long-term follow-up from the British Columbia cohort study [ J]. J Nail Cancer Inst, 2009, 101 (10) :721-728.
  • 7杨安素,涂权梅,朱雪琼.HPV检测早期筛查宫颈癌的临床意义——附妇科门诊2761例宫颈拭子HPV分析[J].中国微生态学杂志,2010,22(10):938-939. 被引量:4
  • 8苏林龙,李力.人乳头状瘤病毒检测联合液基细胞学检查筛查宫颈癌前病变及宫颈癌的意义[J].中国基层医药,2014,21(24):3809-3810. 被引量:4
  • 9Rodrfgnez AC, Schiffman M, Herrero R, et al. Longitudinal study of human papillomavirus persistence and cervical intraepithelial neoplasia grade 2/3 : critical role of duration of infection [ J ]. J Nail Cancer Inst,2010,102(5) :315-324.
  • 10Castle PE, Schiffman M, Wheeler CM, et al. Impact of improved classification on the association of human papillomavirus with cer- vical precancer [ J ]. Am J Epidemio1,2010,171 ( 2 ) : 155-163.

二级参考文献32

  • 1郎景和.子宫颈病变防治的几个问题[J].世界医学杂志,2004,8(11):1-3. 被引量:84
  • 2杨英捷,赵健,李雪倩,廖秦平.人乳头状瘤病毒不同亚型感染与宫颈病变的相关性[J].中国妇产科临床杂志,2006,7(4):253-256. 被引量:54
  • 3MEISEL A, FOVTIN R, ROY M. Condylomatous lesionsof the cerix Ⅱ. Cytologic, colposcopic and histopathologic study [ J ]. Acta Cytol, 1977, 21 (3) :379-390.
  • 4WEAVER B A. Epidemiology and natural history of genital human papillomavirus infection [ J ]. J Am Osteopath Assoc, 2006, 106(3 Suppl 1 ) : S2-S8.
  • 5BACHTIARY B, OBEMAIR A, DREIER B, et al. Impact of multiple HPV infection on response to trentment and survival in patients receiv- ingradical radiotheraphy for cervical cancer [ J ]. Int J Cancer, 2002, 102(3) :237-243.
  • 6LEE S A,KANG D,SEO S S,et al. Multiple HPV infection in cervical cancer screened by HPV DNA chip [ J ]. Cancer Lett, 2003,198 ( 2 ) : 187-192.
  • 7JENKINS D ,JOHNNAON C, GALLIVAN S. Can papillomavims testing be used to improve cervical cancer screening? [J]. Int J Cancer, 1996,65 (6) :768-773.
  • 8BULK S, BERKHOF J, BULKMANS N W, et al. Preferential risk of HPV16 for squamous cell carcinoma and of HPV18 for adenocarcinoma of the cervix compared to women with normal cytology in the Netherlans [J]. Br J Cancer,2006,94( 1 ) :171-175.
  • 9ZUR HAUSEN H. Papillo mariruses and cancer, from basic tudies to clinical application [ J ]. Nat Rel Cancer,2002,2 ( 5 ) :342-350.
  • 10刘继红.人乳头状瘤病毒与子宫颈癌及癌前病变//连利娟,林巧稚.妇科肿瘤学[M].4版,北京:人民卫生出版社,2006:279-285.

共引文献14

同被引文献41

  • 1宫颈癌及癌前病变规范化诊疗指南(试行)[J].慢性病学杂志,2013(6):401-410. 被引量:98
  • 2陈涛利,卞翠翠,杨雷,刘子玲.早期高危宫颈癌患者术后不同治疗方案的临床疗效[J].中国老年学杂志,2015,35(1):55-57. 被引量:25
  • 3Kim K, Zang R, Choi SC, et al. Current status of gynecological cancer in China [ J ]. Gynecol Onco, 2009,20 ( 2 ) :72. DOI: 10. 3802/jgo. 2009.20.2.72.
  • 4Cruiekshank ME. The role of human papillomavirus in risk man- agement [ J ]. Gynaecol Practice, 2003,3 : 2292-2331. DOI: 10. 1016/S1471-7697 (03) 00057-1.
  • 5Abraham J, Stenger M. Cobas HPV test for first-line screening for cervical cancer [ J ]. J Community Support 0ncol,2014,12 ( 5 ) : 156-157.
  • 6Park IU, Wojtal N, Silvrberg M J, et al. Cytology and human papil- lomavirus co-test results preceding incident high-grade cervical intraepithelial neoplasia[J]. Plos One, 2015,10 ( 3 ) : e0118938. DOI : 10. 1371/joumal. pone. 0118938.
  • 7Kucera R, Cerna M, Narsanska A, et al. Growth factors and breast tumors, comparison of selected growth factors with traditional tumor markers[J]. Anticancer Res,2011,31 (12) :4653-4656.
  • 8Poggio JL. Premalignant lesions of the anal canal and squamous cell carcinoma of the anal canal [ J 1. Clin Colon Rectal Surg, 2011,24 ( 3 ) : 177. DOI : 10.1055/s-0031-1286002.
  • 9Farzaneh F, Shahghassempour S, Nosbine B, et al. Application oftumor markers SCC-Ag, CEA,and TPA in patients with cervical precancerous lesions[ J]. Asian Pac J Cancer Prey,2014,15 (9) : 3911-3914.
  • 10Chmura A, Wojcieszek A, Mrochem J, et al. Usefulness of the SCC, CEA, CYFRA 21-1, and CRP markers for the diagnosis and monitoringof cervical squahaous cell carcinoma [ J ]. Ginekol Pol, 2009,80(5) :361-366.

引证文献5

二级引证文献19

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部